ArticleFrontiers in cardiovascular medicine2025
Development of a standardized ovine aortic stenosis model: a pathomimetic platform for TAVI evaluation and durability testing.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aortic valve disease: Novel animal models for advancing our understanding of the underlying mechanisms.Animal models and experimental medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transcatheter aortic valve implantation (TAVI) has gained widespread clinical acceptance owing to its minimally invasive approach and enhanced postoperative recovery. This study developed a standardized ovine aortic stenosis (AS) model through surgical implantation of a circular bioengineered annular stent in the aortic root, creating a reproducible pathomimetic platform for TAVI evaluation. Following hemodynamic stabilization, TAVI procedures were performed to systematically assess mid-to-long-term valve functionality and calcification progression. Methods: AS model was established in 11 sheep using extracorporeal circulation assistance technology. Following hemodynamic stabilization (2-4 weeks), TAVI was performed. The modeled sheep were divided into two groups to monitor valve conditions at 3 months ( Results: Successful AS model establishment was achieved in all 11 sheep, with significant increases in mean transvalvular pressure gradient (Δ+17.98 ± 12.71 mmHg) and peak flow velocity observed post-modeling (Δ+ 2.23 ± 0.38 m/s). Post-TAVI evaluation demonstrated progressive hemodynamic normalization, achieving pre-modeling levels (1.72 vs. 6.91 mmHg, Conclusions: The surgically induced ovine AS model effectively replicates clinically relevant hemodynamic perturbations while maintaining excellent procedural feasibility. TAVI in this model achieves complete hemodynamic normalization without accelerating bioprosthetic valve degeneration or calcification. This standardized preclinical platform enables rigorous evaluation of TAVI device performance and durability, providing robust scientific validation for translational applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.